Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

vWF MAb inhibits stent thrombosis at high shear rates

March 21, 2001

Antithrombotic action of DX-9065a and enoxaparin compared

March 21, 2001

Combined roxifiban/Innohep has improved safety/efficacy ratio

March 21, 2001

Argatroban enters phase II for ischemic stroke

March 16, 2001

XV-454 compares favorably to abciximab in flow models of thrombosis in vitro

March 16, 2001

Human factor Xa inhibitor JTV-803 is a promising orally active antithrombotic agent

March 14, 2001

Single-injection thrombolytic introduced in the E.U.

March 13, 2001

Emisphere begins phase I evaluation of heparin tablets with SNAD delivery system

March 13, 2001

Heterobicyclic inhibitors of factor Xa synthesized at DuPont as potential new anticoagulants

March 12, 2001

Pharmacokinetics, pharmacodynamics of melagatran examined under different conditions

March 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...